Inflammatory Pain Therapeutic Market is segemented By Treatment (Non-Steroidal Anti-Inflammatory Dru...
Market Size in USD Bn
CAGR6.00%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 6.00% |
Market Concentration | High |
Major Players | Pfizer Inc., Roche Holding AG, Novartis AG, Johnson & Johnson, Merck & Co., Inc. and Among Others |
The inflammatory pain therapeutic market is estimated to be valued at USD 5.05 billion in 2025 and is expected to reach USD 7.59 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.00% from 2025 to 2032.
There has been consistent rise in use of prescription drugs to manage inflammatory pain indicating growth in awareness and healthcare spending, which is driving the market growth.